/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Paroxysmal supraventricular tachycardia with no basal ventriculoatrial conduction at the tachycardia cycle length in the electrophysiological study, what is the mechanism?
Event: EHRA 2019
Topic: Diagnostic Methods
Session: Atrial Fibrillation - Clinical
Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.
Event: EHRA 2019
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Implantable Cardioverter / Defibrillator
Atrial fibrillation predictors in patient with embolic strokes of undetermined source
Event: EHRA 2019
Topic: Mechanisms for Stroke
Session: Atrial Fibrillation - Stroke Prevention
ESC 365 is supported by
